글로벌 연구동향
방사선종양학
- 2021년 11월호[Front Oncol.] Efficacy of Whole-Ventricular Radiotherapy in Patients Undergoing Maximal Tumor Resection for Glioblastomas Involving the Ventricle
연세의대 / 김경환, 장종희*, 윤홍인*2021 Sep 21댓글: 0조회수: 1177
- 2021년 11월호[Ann Transl Med.] Current usage of stereotactic body radiotherapy for oligometastatic prostate cancer in Korea: patterns of care survey (KROG 19-08)
서울의대 / 배선현, 김진호*2021 Aug댓글: 0조회수: 1037
- 2021년 11월호[Radiat Oncol .] Radiotherapy dose-volume parameters predict facial lymphedema after concurrent chemoradiation for nasopharyngeal carcinoma
부산의대 / 김동현, 기용간*2021 Sep 6댓글: 0조회수: 1088
- 2021년 10월호[Radiother Oncol.] Image-based deep learning model for predicting pathological response in rectal cancer using post-chemoradiotherapy magnetic resonance imaging
직장암의 항암방사선치료 반응 예측위한 MRI 영상기반 딥러닝 모델분당서울대병원 / 장범섭, 임유진, 이윤진*, 김재성*2021 Aug댓글: 0조회수: 1453
- 2021년 10월호[Radiat Oncol.] Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible
분당서울대병원 / 이태훈, 엄근용*2021 Aug 12댓글: 1조회수: 1240
- 2021년 10월호[J Clin Med.] Predictive Role of Prior Radiotherapy and Immunotherapy-Related Adverse Effects in Advanced NSCLC Patients Receiving Anti-PD-1/L1 Therapy
가톨릭대, 울산의대 / 임정욱, 김수한, 여창동*, 최창민*2021 Aug 21댓글: 0조회수: 1155
- 2021년 10월호[Cancers (Basel).] Definitive Chemoradiotherapy versus Radical Hysterectomy Followed by Tailored Adjuvant Therapy in Women with Early-Stage Cervical Cancer Presenting with Pelvic Lymph Node Metastasis on Pretreatment Evaluation: A Propensity Score Matching Analysis
울산의대, 국립암센터 / 박종무, 김연주, 김영석*, 김주영*2021 Jul 23댓글: 0조회수: 1058
- 2021년 10월호[Radiat Oncol.] Treatment outcomes of passive scattering proton beam therapy for stage I non-small cell lung cancer.
국립암센터 / Unurjargal Bayasgalan, 서양권*2021 Aug 18댓글: 0조회수: 1122
- 2021년 10월호[Radiat Oncol.] Efficacy of radiotherapy for gastric bleeding associated with advanced gastric cancer
연세의대 / 이준교, 성진실*2021 Aug 23댓글: 1조회수: 1138
- 2021년 10월호[J Cancer Res Clin Oncol.] Adjuvant radiotherapy and chemotherapy offer a recurrence and survival benefit in patients with resected perihilar cholangiocarcinoma.
연세의대 / 임정호, 성진실*2021 Aug댓글: 1조회수: 1080

